bf/NASDAQ:MRSN_icon.jpeg

COM:MERSANA

Mersana Therapeutics

  • Stock

Last Close

2.22

21/11 21:00

Market Cap

239.83M

Beta: -

Volume Today

1.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-16.43M
-
-13.70M
16.61%
-38.71M
182.53%
-64.26M
66.01%
-28.21M
56.10%
-88.05M
212.13%
-170.06M
93.15%
-204.21M
20.08%
-171.67M
15.94%
depreciation and amortization
297K
-
655K
120.54%
928K
41.68%
1.26M
35.45%
1.25M
0.95%
1.01M
18.88%
855K
15.35%
927K
8.42%
1.52M
63.65%
deferred income tax
-349K
-
-102K
70.77%
-134K
31.37%
-386K
188.06%
-222K
42.49%
-86K
61.26%
-23.92M
-
stock based compensation
349K
-
668K
91.40%
1.42M
112.87%
3.88M
173.14%
4.87M
25.44%
7.17M
47.21%
18.41M
156.68%
21.52M
16.91%
21.14M
1.79%
change in working capital
6.15M
-
43.97M
615.34%
-6.03M
113.71%
4.18M
169.27%
-45.53M
1,190.37%
5.11M
111.21%
10.09M
97.55%
133.10M
1,219.77%
-18.76M
114.10%
accounts receivables
1.20M
-
-411K
134.34%
267K
164.96%
325K
21.72%
459K
41.23%
-30M
-
30M
200%
inventory
304K
-
1.42M
367.43%
2.42M
70.44%
2.61M
7.72%
-1.50M
157.57%
accounts payables
926K
-
-325K
135.10%
1.33M
510.77%
7.38M
452.43%
-3.11M
142.17%
942K
130.29%
483K
48.73%
947K
96.07%
-6.08M
742.03%
other working capital
3.72M
-
43.28M
1,063.75%
-10.05M
123.23%
-6.13M
38.99%
-41.38M
574.73%
4.16M
110.06%
9.60M
130.65%
162.15M
1,588.73%
-42.68M
126.32%
other non cash items
349K
-
102K
70.77%
-159K
255.88%
110K
169.18%
103K
6.36%
148K
43.69%
723K
388.51%
-699K
196.68%
22.82M
3,364.38%
net cash provided by operating activities
-9.64M
-
31.59M
427.81%
-42.68M
235.11%
-55.22M
29.38%
-67.74M
22.69%
-74.70M
10.26%
-139.99M
87.41%
-49.36M
64.74%
-168.88M
242.12%
investments in property plant and equipment
-619K
-
-1.08M
75.12%
-1.14M
5.44%
-1.37M
19.86%
-605K
55.84%
-473K
21.82%
-648K
37.00%
-2.20M
239.04%
-2.17M
1.32%
acquisitions net
26.69M
-
150.52M
-
purchases of investments
-145.70M
-
-53.69M
-
-247.52M
-
-155.92M
37.01%
sales maturities of investments
47.22M
-
88.56M
87.56%
27M
69.51%
37.50M
38.89%
97M
-
277.97M
186.57%
other investing activites
-164K
-
-26.69M
-
-150.52M
-
net cash used for investing activites
-783K
-
-1.08M
38.44%
-99.62M
9,090.41%
87.19M
187.52%
-27.29M
131.30%
37.03M
235.66%
-648K
101.75%
-152.72M
23,467.28%
119.88M
178.50%
debt repayment
-87K
-
-313K
259.77%
-5.70M
1,721.41%
-272K
95.23%
-93.13M
34,137.87%
common stock issued
68.14M
-
92.16M
-
227.03M
146.33%
43.09M
81.02%
150.89M
250.21%
1.55M
98.97%
common stock repurchased
146K
-
489K
234.93%
561K
14.72%
640K
14.08%
1.06M
66.41%
1.12M
5.26%
dividends paid
-489K
-
-561K
14.72%
-640K
14.08%
-94.94M
-
other financing activites
9.96M
-
58.26M
484.93%
452K
99.22%
918K
103.10%
5.63M
513.18%
3.70M
34.29%
26.26M
609.92%
1.33M
94.93%
-1.12M
184.22%
net cash used provided by financing activities
9.96M
-
58.26M
484.93%
68.60M
17.74%
1.06M
98.45%
97.70M
9,082.71%
230.41M
135.83%
63.65M
72.38%
153.02M
140.42%
94.67M
38.13%
effect of forex changes on cash
net change in cash
-459K
-
88.76M
19,438.34%
-73.71M
183.04%
33.04M
144.83%
2.67M
91.93%
192.74M
7,126.96%
-76.99M
139.94%
-49.06M
36.27%
45.68M
193.10%
cash at beginning of period
11.99M
-
11.53M
3.83%
100.30M
769.58%
26.96M
73.12%
60.01M
122.55%
62.67M
4.44%
255.41M
307.54%
178.43M
30.14%
128.88M
27.77%
cash at end of period
11.53M
-
100.30M
769.58%
26.59M
73.49%
60.01M
125.66%
62.67M
4.44%
255.41M
307.54%
178.43M
30.14%
129.36M
27.50%
174.56M
34.94%
operating cash flow
-9.64M
-
31.59M
427.81%
-42.68M
235.11%
-55.22M
29.38%
-67.74M
22.69%
-74.70M
10.26%
-139.99M
87.41%
-49.36M
64.74%
-168.88M
242.12%
capital expenditure
-619K
-
-1.08M
75.12%
-1.14M
5.44%
-1.37M
19.86%
-605K
55.84%
-473K
21.82%
-648K
37.00%
-2.20M
239.04%
-2.17M
1.32%
free cash flow
-10.26M
-
30.50M
397.45%
-43.82M
243.66%
-56.59M
29.13%
-68.35M
20.79%
-75.17M
9.98%
-140.64M
87.09%
-51.56M
63.34%
-171.05M
231.75%

All numbers in (except ratios and percentages)